Skip to main content
Clinical Trials/NCT04389554
NCT04389554
Completed
Not Applicable

Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19

Kanuni Sultan Suleyman Training and Research Hospital1 site in 1 country300 target enrollmentMay 14, 2020
ConditionsCOVID-19D-dimer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Enrollment
300
Locations
1
Primary Endpoint
Compare D-dimer values of COVID-19 patients and healthy pregnant women
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.

Registry
clinicaltrials.gov
Start Date
May 14, 2020
End Date
May 29, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Merve Aldikactioglu Talmac, MD

Specialist of Obstetrics and Gynecology

Kanuni Sultan Suleyman Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Pregnant women with COVID-19

Exclusion Criteria

  • Having a chronic disease that raises D-dimer levels

Outcomes

Primary Outcomes

Compare D-dimer values of COVID-19 patients and healthy pregnant women

Time Frame: one day

Study Sites (1)

Loading locations...

Similar Trials